Hai Feng

1.4k total citations
32 papers, 1.1k citations indexed

About

Hai Feng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hai Feng has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Hai Feng's work include MicroRNA in disease regulation (3 papers), Cancer Mechanisms and Therapy (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Hai Feng is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cancer Mechanisms and Therapy (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Hai Feng collaborates with scholars based in China, Hong Kong and United States. Hai Feng's co-authors include Alfred S.L. Cheng, Joseph J.�Y. Sung, Zhuo Yu, Ka‐Fai To, Jun Yu, May S. Li, Yueqiu Gao, Peter Morin Nissom, Niki S.C. Wong and Miranda G.S. Yap and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hai Feng

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai Feng China 17 667 259 169 132 121 32 1.1k
Xiangxuan Zhao China 19 780 1.2× 386 1.5× 189 1.1× 89 0.7× 121 1.0× 39 1.2k
Eun Ju Kim South Korea 18 606 0.9× 249 1.0× 159 0.9× 180 1.4× 65 0.5× 57 1.2k
Fujun Li China 20 607 0.9× 202 0.8× 345 2.0× 125 0.9× 186 1.5× 62 1.3k
Pei‐Ming Yang Taiwan 24 819 1.2× 335 1.3× 266 1.6× 183 1.4× 131 1.1× 57 1.4k
Shuang Cao China 19 573 0.9× 289 1.1× 169 1.0× 96 0.7× 120 1.0× 59 1.1k
Deguang Sun China 20 1.1k 1.6× 254 1.0× 223 1.3× 91 0.7× 131 1.1× 39 1.4k
Xiaojie Ma China 23 762 1.1× 190 0.7× 140 0.8× 233 1.8× 154 1.3× 68 1.5k
Sonja M. Kessler Germany 22 630 0.9× 465 1.8× 132 0.8× 238 1.8× 115 1.0× 41 1.1k
Lihong Chen China 20 1.1k 1.7× 297 1.1× 478 2.8× 186 1.4× 123 1.0× 50 1.7k
Steffen Frese Switzerland 17 544 0.8× 108 0.4× 151 0.9× 116 0.9× 204 1.7× 26 979

Countries citing papers authored by Hai Feng

Since Specialization
Citations

This map shows the geographic impact of Hai Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Feng more than expected).

Fields of papers citing papers by Hai Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Feng. The network helps show where Hai Feng may publish in the future.

Co-authorship network of co-authors of Hai Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Feng. A scholar is included among the top collaborators of Hai Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Feng. Hai Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuyao, Xiaona Lu, Weijia Du, et al.. (2025). Nanodelivery of arsenic trioxide induces macrophage-governed cGAS-STING signaling to remodel immune microenvironment in hepatocellular carcinoma. Chemical Engineering Journal. 506. 159943–159943. 3 indexed citations
2.
Zhang, Xuemei, et al.. (2024). Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects. Pharmaceuticals. 17(9). 1142–1142. 2 indexed citations
3.
Lu, Xiaona, K. Liu, Zuo‐Feng Zhang, et al.. (2024). Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
4.
Lu, Xiaona, Yuyao Li, Yue Li, et al.. (2024). Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling. Phytomedicine. 126. 155395–155395. 13 indexed citations
5.
Zhang, Zuo‐Feng, Kun Liu, Xiaona Lu, et al.. (2024). Late-onset Cholestasis with Paucity of Portal Area Secondary to HNF1β Deficiency in Adulthood: A Case Report. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
6.
Lu, Xiaona, Yuyao Li, Yue Li, et al.. (2023). Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles. Frontiers in Molecular Biosciences. 10. 1114594–1114594. 5 indexed citations
7.
8.
Li, Yuyao, Yue Li, Jinghao Zhang, et al.. (2022). Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 15 indexed citations
9.
Yu, Zhuo, Yuyao Li, Yue Li, et al.. (2022). Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 10(5). e004297–e004297. 90 indexed citations
10.
Feng, Hai, Xuemei Zhang, Yuyao Li, et al.. (2022). Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy. SHILAP Revista de lepidopterología. Volume 9. 1109–1125. 20 indexed citations
11.
Li, Yuyao, Yue Li, Xuemei Zhang, et al.. (2022). A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma. Frontiers in Oncology. 12. 986827–986827. 6 indexed citations
12.
Feng, Hai, et al.. (2021). Mediation of circ_RPPH1 on miR-146b-3p/E2F2 pathway to hinder the growth and metastasis of breast carcinoma cells. Aging. 13(16). 20552–20568. 13 indexed citations
13.
14.
Hamilton, Amy L., Michael A. Kamm, Peter De Cruz, et al.. (2020). Luminal microbiota related to Crohn’s disease recurrence after surgery. Gut Microbes. 11(6). 1713–1728. 29 indexed citations
15.
Song, Haibin, Zhuo Yu, Xuehua Sun, et al.. (2018). Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling. EBioMedicine. 35. 155–166. 40 indexed citations
16.
Yu, Zhuo, Hai Feng, Xuehua Sun, et al.. (2018). Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase. Scientific Reports. 8(1). 3891–3891. 27 indexed citations
17.
Lau, Kin‐Mang, Jesse Pang, Walter Wai Yeung, et al.. (2012). Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Acta Neuropathologica. 123(4). 553–571. 19 indexed citations
18.
Cheng, Alfred S.L., Suki S. Lau, Yangchao Chen, et al.. (2011). EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis. Cancer Research. 71(11). 4028–4039. 180 indexed citations
19.
Yu, Jun, Bo Shen, Eagle S.H. Chu, et al.. (2010). Inhibitory Role of Peroxisome Proliferator-Activated Receptor Gamma in Hepatocarcinogenesis in Mice and in Vitro. Hepatology. 51(6). 2008–2019. 102 indexed citations
20.
Wong, Niki S.C., et al.. (2010). An investigation of intracellular glycosylation activities in CHO cells: Effects of nucleotide sugar precursor feeding. Biotechnology and Bioengineering. 107(2). 321–336. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangxuan Zhao Breakdown of academic impact, for papers by Eun Ju Kim Breakdown of academic impact, for papers by Fujun Li Breakdown of academic impact, for papers by Pei‐Ming Yang Breakdown of academic impact, for papers by Shuang Cao Breakdown of academic impact, for papers by Deguang Sun Breakdown of academic impact, for papers by Xiaojie Ma Breakdown of academic impact, for papers by Sonja M. Kessler Breakdown of academic impact, for papers by Lihong Chen Breakdown of academic impact, for papers by Steffen Frese
Rankless by CCL
2026